X-55009268-C-G

Variant summary

Our verdict is Uncertain significance. Variant got 3 ACMG points: 4P and 1B. PM2PP5_ModerateBP4

The NM_000032.5(ALAS2):​c.1676G>C​(p.Arg559Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).

Frequency

Genomes: not found (cov: 23)

Consequence

ALAS2
NM_000032.5 missense

Scores

11
6

Clinical Significance

Likely pathogenic criteria provided, single submitter P:1

Conservation

PhyloP100: -0.306
Variant links:
Genes affected
ALAS2 (HGNC:397): (5'-aminolevulinate synthase 2) The product of this gene specifies an erythroid-specific mitochondrially located enzyme. The encoded protein catalyzes the first step in the heme biosynthetic pathway. Defects in this gene cause X-linked pyridoxine-responsive sideroblastic anemia. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
APEX2 (HGNC:17889): (apurinic/apyrimidinic endodeoxyribonuclease 2) Apurinic/apyrimidinic (AP) sites occur frequently in DNA molecules by spontaneous hydrolysis, by DNA damaging agents or by DNA glycosylases that remove specific abnormal bases. AP sites are pre-mutagenic lesions that can prevent normal DNA replication so the cell contains systems to identify and repair such sites. Class II AP endonucleases cleave the phosphodiester backbone 5' to the AP site. This gene encodes a protein shown to have a weak class II AP endonuclease activity. Most of the encoded protein is located in the nucleus but some is also present in mitochondria. This protein may play an important role in both nuclear and mitochondrial base excision repair. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP5
Variant X-55009268-C-G is Pathogenic according to our data. Variant chrX-55009268-C-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 214100.Status of the report is criteria_provided_single_submitter, 1 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.3853199). . Strength limited to SUPPORTING due to the PP5.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALAS2NM_000032.5 linkc.1676G>C p.Arg559Pro missense_variant Exon 11 of 11 ENST00000650242.1 NP_000023.2 P22557-1
APEX2NM_014481.4 linkc.*1833C>G downstream_gene_variant ENST00000374987.4 NP_055296.2 Q9UBZ4E5KN95

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALAS2ENST00000650242.1 linkc.1676G>C p.Arg559Pro missense_variant Exon 11 of 11 NM_000032.5 ENSP00000497236.1 P22557-1
APEX2ENST00000374987.4 linkc.*1833C>G downstream_gene_variant 1 NM_014481.4 ENSP00000364126.3 Q9UBZ4

Frequencies

GnomAD3 genomes
Cov.:
23
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
23

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Pathogenic:1
Jan 08, 2013
GeneDx
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

p.Arg559Pro (CGC>CCC): c.1676 G>C in exon 11 of the ALAS2 gene (NM_000032.4). The R559P missense change likely associated with hereditary X-linked sideroblastic anemia was identified in the ALAS2 gene. It has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The amino acid change is non-conservative in that a positively charged Arginine residue is replaced by an uncharged Proline residue with a unique ring structure. This change occurs at a position in the ALAS2 protein where a basic amino acid is conserved in mammals. Furthermore, most in-silico analysis models predict that R559P is damaging to the ALAS2 protein. Therefore, R559P is a strong candidate for a disease-causing mutation, however the possibility that it is a benign variant cannot be excluded. The variant is found in MITONUC-MITOP panel(s). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.39
BayesDel_addAF
Uncertain
0.063
T
BayesDel_noAF
Benign
-0.15
CADD
Benign
7.9
DANN
Uncertain
0.99
DEOGEN2
Benign
0.39
.;T;T;.
FATHMM_MKL
Benign
0.25
N
LIST_S2
Uncertain
0.95
D;.;D;D
M_CAP
Uncertain
0.14
D
MetaRNN
Benign
0.39
T;T;T;T
MetaSVM
Uncertain
0.44
D
MutationAssessor
Uncertain
2.0
.;M;M;.
PrimateAI
Benign
0.22
T
PROVEAN
Uncertain
-2.4
N;.;N;N
REVEL
Uncertain
0.43
Sift
Uncertain
0.018
D;.;D;D
Sift4G
Uncertain
0.023
D;.;D;D
Polyphen
0.74
.;P;P;.
Vest4
0.40
MutPred
0.63
.;Loss of helix (P = 0.079);Loss of helix (P = 0.079);.;
MVP
0.78
MPC
1.1
ClinPred
0.87
D
GERP RS
-3.5
Varity_R
0.89
gMVP
0.90

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs145704441; hg19: chrX-55035701; API